Ozanezumab pharmacokinetic parameters.

*Two doses, received 4 weeks apart. AUC0–Week 4, area under the plasma concentration-time curve up to Week 4; AUC0–∞, area under the plasma concentration-time curve up to infinity; Cmax, maximum observed plasma concentration; n, number of subjects; RD, repeated dose; SD, single dose; t1/2, apparent terminal phase half-life; Tmax, time at which Cmax was observed. Tmax presented as median (range); all other values presented as geometric mean of the log-transformed data (coefficient of variation, CV%).